Drug intelligence / Profile preview

propylene glycol preservative-free artificial tears

Development stage: Unknown
Lead developer: Alcon
Modality: Small Molecules
Administration: Ophthalmic

Overview

Propylene glycol preservative-free artificial tears are a topical ophthalmic lubricant used to relieve ocular irritation and dryness. In the context of clinical research conducted by the Retina Research Institute, LLC, this formulation is utilized as a placebo comparator in Phase 4 trials evaluating the management of post-procedural pain following intravitreal injections. As a humectant, propylene glycol works by increasing the viscosity of the tear film and providing a protective, lubricating layer over the corneal surface, thereby reducing discomfort associated with ocular surface disruption during medical procedures.

Other names: propylene glycol ophthalmic solutionartificial tears

Beyond the preview

Go deeper on propylene glycol preservative-free artificial tears.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on propylene glycol preservative-free artificial tears.

Explore the full profile